tiprankstipranks
SWK Holdings Corporation (SWKH)
NASDAQ:SWKH
US Market

SWK Holdings (SWKH) Earnings Dates, Call Summary & Reports

Compare
32 Followers

Earnings Data

Report Date
May 14, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.29
Last Year’s EPS
0.12
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 20, 2025
|
% Change Since: 7.38%
|
Next Earnings Date:May 14, 2025
Earnings Call Sentiment|Positive
SWK Holdings reported strong financial results with several successful loan transactions and repayments, contributing to a solid cash position. However, challenges remain with non-accrual receivables and decreased revenue in the Finance Receivables segment due to non-accrual investments. Overall, the positive developments and strong cash generation outweigh the negatives.
Company Guidance
During the SWK Holdings Fourth Quarter 2024 Conference Call, key financial metrics were discussed highlighting the company's strong performance. The finance segment net income was $8.2 million, and capital deployment into life science finance receivables totaled $44 million. The non-GAAP tangible financing book value per share increased by 8% year-over-year to $21.15. SWK repurchased approximately 100,000 shares at $1.6 million since September 2024. A $4.2 million payment from Veru, $12.2 million from MolecuLight, and $17.25 million from ANI Pharma were received, generating IRRs of 45%, 20%, and 20% respectively. The effective yield of the portfolio was 15.5%. The company held over $30 million in cash with no borrowings under its revolver, and anticipated a dividend after a $34 million royalty portfolio sale. MOD3 Pharma's revenue tripled to $3.6 million in 2024, supporting expectations for growth in 2025. The company reported GAAP pretax net income of $8.6 million, or $0.70 per diluted share, with a 5% increase in GAAP book value per share to $23.45.
Solid Financial Performance
SWK Holdings reported $8.2 million of net income in the finance segment, with an 8% increase in non-GAAP tangible financing book value per share to $21.15.
Successful Capital Deployment
Deployed $44 million into yielding finance receivables to life science companies, indicating strong operational activity.
Strategic Loan Transactions
Closed multiple significant loans, including an up to $8 million senior secured term loan to Triple Ring Technologies and a $15 million term loan with Impedimed.
Successful Receivable Repayments
Three finance receivables were repaid at premiums, including a 45% IRR from Veru's $4.2 million payment and a 20% IRR from MolecuLight's $12.2 million payment.
MOD3 Pharma Revenue Growth
MOD3 Pharma, formerly Enteris CDMO, tripled its revenue from $1.2 million in 2023 to $3.6 million in 2024, with expectations for continued growth.
Strong Cash Position
SWK Holdings has over $30 million in cash, with no borrowings under its revolver, and expects to increase cash to nearly $70 million following the close of transactions.
---

SWK Holdings (SWKH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SWKH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 14, 20252025 (Q1)
0.29 / -
0.123
Mar 20, 20252024 (Q4)
0.94 / 0.54
0.229135.81% (+0.31)
Nov 14, 20242024 (Q3)
0.52 / 0.33
0.382-13.61% (-0.05)
Aug 15, 20242024 (Q2)
0.49 / 0.47
0.40117.21% (+0.07)
May 15, 20242024 (Q1)
0.47 / 0.12
0.446-72.42% (-0.32)
Mar 21, 20242023 (Q4)
0.42 / 0.23
0.12780.31% (+0.10)
Nov 09, 20232023 (Q3)
0.41 / 0.38
0.64-40.31% (-0.26)
Aug 09, 20232023 (Q2)
0.40 / 0.40
0.164144.51% (+0.24)
May 11, 20232023 (Q1)
- / -
0.466
Apr 03, 20232022 (Q4)
0.35 / 0.45
0.466-4.29% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SWKH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 20, 2025$16.40$17.50+6.71%
Nov 14, 2024$16.26$16.10-0.98%
Aug 15, 2024$16.83$16.94+0.65%
May 15, 2024$17.65$17.36-1.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does SWK Holdings Corporation (SWKH) report earnings?
SWK Holdings Corporation (SWKH) is schdueled to report earning on May 14, 2025, TBA Not Confirmed.
    What is SWK Holdings Corporation (SWKH) earnings time?
    SWK Holdings Corporation (SWKH) earnings time is at May 14, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SWKH EPS forecast?
          SWKH EPS forecast for the fiscal quarter 2025 (Q1) is 0.29.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis